Stockreport

Amedica Announces Successful Completion of First Valeo® C+CSC with Lumen Interbody Fusion Surgery

AMEDICA CORP COMMON STOCK  (AMDA) 
US:NASDAQ Investor Relations: investors.amedica.com
PDF SALT LAKE CITY, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company that develops and commercializes silicon nitrid [Read more]